期刊文献+

葫芦素E诱导肝癌细胞凋亡及其机制 被引量:9

Mechanism of cucurbitacin E-induced apoptosis of hepatocarcinoma cells
下载PDF
导出
摘要 目的探讨葫芦素E对肝癌细胞形态学方面的影响及其机制。方法用不同浓度的葫芦素E孵育HepG2细胞6h,分别通过MTT检测药物对细胞的生长抑制作用、激光共聚焦显微镜观测细胞形态变化、流式细胞仪检测细胞凋亡比率、Western blot检测凋亡相关蛋白的表达变化。结果经过葫芦素E孵育后,HepG2细胞的生长受到显著抑制,形态学上胞膜发生翻转,为典型细胞凋亡形态变化,流式细胞检测发现,随着葫芦素E药物浓度的升高,细胞凋亡比率上升。同时,细胞中活化的Caspase 3蛋白比例上升。体内实验表明,葫芦素E可以提高Bax蛋白表达,促使裸鼠人原位移植肝癌细胞核酸断裂。结论葫芦素E可以影响HepG2细胞形态学改变,并诱导体内与体外HepG2细胞发生凋亡,而且呈现药物浓度依赖性。 Purpose To study the morphoalogical changes of HepG2 cells after cucurbitacin E( CuE) treatment and the molecular mechanisms involved in this phenomenon. Methods HepG2 cells were treated with different doses of CuE for six hours and detected by confocal microscopy for morphological study. The inhibitory ratio of cell growth and percentage of cellular apoptosis were analyzed by MTT and flow cytometry,respectively. Additionally,the expression pattern of apoptosis-related protein was evaluated by Western blot.Results After treatment by CuE,HepG2 cells were observed as typical apoptotic cells. The results of MTT and FACS showed that CuE could inhibit cell growth and induce apoptosis of HepG2 in a dose-dependent manner. Also,pro-Caspase 3 was cleaved to active form Caspase 3. The results from in vivo experiments showed that CuE could up-regulate the expression of Bax and induce the cleavage of DNA in hepatocarcinoma cells. Conclusions CuE could trigger apoptosis of HepG2 cells characterized by apparent morphological changes,which provides scientific information for CuE treatment of liver cancer.
出处 《临床与实验病理学杂志》 CAS CSCD 北大核心 2015年第12期1339-1343,共5页 Chinese Journal of Clinical and Experimental Pathology
基金 安徽省自然科学基金(1508085MH173)
关键词 肝肿瘤 葫芦素E 肝癌细胞 细胞凋亡 hepatic neoplasms cucurbitacin E HepG2 apoptosis
  • 相关文献

参考文献14

  • 1Hung C M, Chang C C, Lin C W, et al. Cucurbitacin E as induc- er of cell death and apoptosis in human oral squamous cell carcino- ma cell line SAS[J]. Int J Mol Sci, 2013,14(8) :17147 -56.
  • 2Rios J L, Aud0jar I, Escandell J M, et al. Cucurbitacins as in- ducers of cell death and a rich source of potential anticancer com- pounds [ J ]. Curr Pharm Des, 2012,18 ( 12 ) : 1663 - 76.
  • 3李艳春,张鹏飞,罗杞瑜,邓意辉,马恩龙,景永奎.葫芦素E通过诱导G_2/M周期阻滞抑制人肝癌细胞增殖[J].沈阳药科大学学报,2010,27(5):388-391. 被引量:5
  • 4Alghasham A A. Cucurbitacins-a promising target for cancer thera- py[J], Int J Health Sci (Qassim), 2013,7(1) :77 -89.
  • 5Zhang T, Li J J, Dong Y M, et al. Cucurbitacin E inhibits breast tumor metastasis by suppressing cell migration and invasion [ J ]. Breast Cancer Res Treat, 2012,135 (2) :445 -58.
  • 6Hsu Y C, Chen M J, Huang T Y. Inducement of mitosis delay by eucurbitacin E, a noveltetracyelic trlterpene from climbing stem of Cucumis melo L. , through GADD45-,/ in human hrain malignant glioma (GBM) 8401 cells[ J]. Cell Death Dis, 2014,5 :e1087.
  • 7Hacker G. The morphology of apoptosis [ J ]. Cell Tissue Res, 2000,301 ( 1 ) :5 - 17.
  • 8Nicholson D W, Ali A, Thornberry N A, et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian ap- optosis[ J]. Nature, 1995,376(6535) :37 -43.
  • 9蓝天,徐谦,刘卫国,金洪传,毛伟敏,王晓稼.葫芦素E对人乳腺癌细胞抑制作用及其机制的探讨[J].中华肿瘤防治杂志,2013,20(14):1065-1069. 被引量:4
  • 10Lan T, Wang L, Xu Q, et al. Growth inhibitory effect of eucurb- itacin E on breast cancer cells[J]. Int J Clin Exp Pathol, 2013,6 (9) :1799 -805.

二级参考文献23

  • 1Jian-Yong Zheng,Guang-Shun Yang,Wei-Zhong Wang,Wen-Xian Guan,Jiang Li,Wen-Liang Wang,Kai-Zong Li.Overexpression of Bax induces apoptosis and enhances drug sensitivity of hepatocellular cancer-9204 cells[J].World Journal of Gastroenterology,2005,11(23):3498-3503. 被引量:2
  • 2FARIAS M R,SCHENKEL E P,MAYER R,et al. Cucurbitacins as constituents of Wilbrandia ebracteata [J]. Planta Medica, 1993,59 (3) :272 - 275.
  • 3CHEN J C,CHIU M H,NIE R L,et al. Cucurbitacins and cucurbitane glycosides: structures and biological activities [ J ]. Natural Product Reports, 2005,22 ( 3 ) : 386 - 399.
  • 4REN Fang-bi, HONG Mi. Cucurbitacins in the treatment of hepatitis and primary liver cancer. Current status of pharmacological and clinical research[ J]. Chin J Integ Trad West Med, 1996,6(10) :633 - 635.
  • 5DUNCAN K L, DUNCAN M D, ALLEY M C, et al. Cucurbitacin E-induced disruption of the actin and vimentin cytoskeleton in prostate carcinoma cells [ J ]. Biochemical Pharmacology, 1996,52 (10) : 1553 - 1560.
  • 6TANNIN-SPITZ T, GROSSMAN S, DOVRAT S, et al. Growth inhibitory activity of cucurbitacin glucosides isolated from Citrullus colocynthis on human breast cancer cells [ J ]. Biochemical Pharmacology, 2007,73 (1) :56 -67.
  • 7SHAPIRO G I. Cyclin-dependent kinase pathways as targets for cancer treatment[ J ]. J Clin Oncol,2006,24 ( 11 ) : 1770 - 1783.
  • 8JESSUS C, OZON R. Function and regulation of Cdc25C protein phosphate through mitosis and meiosis [J]. Prog Cell Cycle Res, 1995,1 ( 1 ) :215 - 228.
  • 9BUNZ F, DUTRIAUX A, LENGAUER C, et al. Requirement for p53 and p21 to sustain G2 arrest after DNA damage [ J ]. Science, 1998,282 ( 5393 ) : 1497 - 1501.
  • 10CHENG M, OLIVIER P, DIEHL J A,et al. The p21 (Cipl) and p27 ( Kipl ) CDK ‘inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts[ J]. The EMBO Journal, 1999, 18 (6): 1571 - 1583.

共引文献13

同被引文献151

引证文献9

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部